Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

Share Price is delayed by 15 minutes
Get Live Data
40.9145    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $25.45b
AXBA Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank 144a Share Chart

General Update

28 Apr 2026 11:20

RNS Number : 2405C
Axis Bank Limited
28 April 2026
 

AXIS/CO/CS/51/2026-27

April 25, 2026

 

Listing & Compliance Department

National Stock Exchange of India LimitedExchange Plaza, 5th FloorPlot No. C/1, "G" BlockBandra-Kurla ComplexBandra (E), Mumbai - 400 051

NSE Symbol: AXISBANK

Listing Department

BSE Limited1st Floor,P. J. Towers,Dalal Street,Fort, Mumbai - 400 001

BSE Scrip Code: 532215

 

Dear Sir(s),

 

SUB: DISCLOSURE UNDER REGULATION 30 OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

 

This is to inform you that the Board of Directors of Axis Bank Limited (the "Bank"), at its meeting held on April 25, 2026, has taken note of the proposed preferential issue of equity shares by its wholly-owned subsidiary Axis Finance Limited ("AFL") to Kedaara Pearl Holding ("KC Investor 1") and Kedaara Capital Fund IV AIF ("KC Investor 2") (KC Investor 1 and KC Investor 2 collectively referred to as the "Investors") and approved the execution of an investor agreement amongst the Bank, AFL and the Investors, in connection with the said preferential issue (the "Investor Agreement").

 

The transaction contemplated under the Investor Agreement is subject to satisfaction of customary conditions and receipt of such statutory / regulatory approvals, as may be applicable.

 

Upon completion of the proposed preferential issue, the Bank will hold 94.92% of the equity shares of AFL and will continue to remain the holding company and promoter of AFL.

 

The details required pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as Annexure A.

 

The Board meeting commenced at 9.00 A.M. and concluded at 4.30 P.M.

 

You are requested to take the above on record.

 

Thanking you,

 

Yours faithfully,

For Axis Bank Limited

 

 

 

Sandeep Poddar

Company Secretary

 

 

Annexure A

 

Sr. No.

Particulars

Details

a.

Parties to the agreements

Axis Bank Limited ("Bank"), Axis Finance Limited ("AFL"), Kedaara Pearl Holding ("KC Investor 1") and Kedaara Capital Fund IV AIF ("KC Investor 2").

 

 

(KC Investor 1 and KC Investor 2 to be collectively referred to as "Investors").

b.

Date of entering into the agreements

Investor Agreement ("IA"): April 25, 2026.

c.

Purpose of entering into the agreements

Preferential issue by AFL of 4,14,90,391 (four crores fourteen lakhs ninety thousand three hundred and ninety one) equity shares of the AFL to KC Investor 1 and 19,09,600 (nineteen lakhs nine thousand and six hundred) equity shares of the AFL to KC Investor 2, on private placement basis, each having face value of Rs. 10 (Indian Rupees 10 only) for Rs. 172.81 (Indian Rupees One Hundred and Seven Two point Eight One only) each.

 

To record the rights and obligations of the Investors agreed amongst the parties in connection with the aforesaid preferential issue of equity shares.

d.

Shareholding, if any, in the entity with whom the agreement is executed

As on the execution date, the Bank holds 100% of the share capital of AFL. Upon completion of the proposed preferential issue, the Bank will hold 94.92% of the equity shares of AFL and will continue to remain the holding company and promoter of AFL.

e.

Significant terms of the agreement (in brief)

(i) Limited reserved matters requiring consent of the Investors

(ii) Pre-emptive right of the Investors

(iii) Tag along right of the Investors in case Bank proposes to transfer any shares

(iv) Prior consent right of Investors for issuance of shares by AFL which leads to dilution of Bank's shareholding below 26%.

(v) Right of first offer of the Bank in case Investors propose to transfer any shares

(vi) Exit rights of the Investors

(vii) Customary transfer restrictions on both Investors and the Bank

(viii) Non-solicitation obligation on both the Investors and the Bank.

f.

Extent and the nature of impact on management or control of the listed entity

IA does not impact management or control of the Bank.

 

Rights given to the Investors under the IA does not amount to control by the Investors on AFL.

 

g.

Details and quantification of the restriction or liability imposed upon the listed entity

(i) Restrictions on ability of the Bank to transfer its shares in AFL without providing a tag along right to the Investors.

(ii) Restriction on AFL to issue shares (which leads to dilution of Bank's shareholding below 26%) without Investors' consent.

(iii) Restriction on AFL to decide on any reserved matter without the prior consent of the Investors.

h.

Whether the said parties are related to promoter / promoter group / group companies in any manner. If yes, nature of relationship

As on the date of this disclosure, AFL is a wholly owned subsidiary of the Bank. However, upon closing of the IA, AFL will remain a subsidiary but cease to be a wholly owned subsidiary of the Bank.

i.

Whether the transaction would fall within related party transactions? If yes, whether the same is done at "arm's length"

Not applicable

j.

In case of issuance of shares to the parties, details of issue price, class of shares issued

Not applicable for the Bank.

k.

Any other disclosures related to such agreements, viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc.

None

l.

In case of rescission, amendment or alteration, listed entity shall disclose additional details to the stock exchange(s)

Not applicable.

 

 http://www.rns-pdf.londonstockexchange.com/rns/2405C_1-2026-4-28.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPURGCUPQGUR
Date   Source Headline
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023
17th Jul 20235:23 pmRNSReclassification of Promoter
27th Jun 20234:12 pmRNSCredit Rating
26th Jun 202312:09 pmRNSNotice of Annual General Meeting and Annual Report
16th Jun 20231:53 pmRNSAppointment of Non-Executive (Part-time) Chairman
30th May 20233:44 pmRNSIntimation of Record date for Dividend
30th May 20233:30 pmRNSAppointment of Additional Independent Director
4th May 20231:49 pmRNSReclassification of Promoter
28th Apr 20233:39 pmRNSAmendment to Articles of Association
28th Apr 20233:25 pmRNSReclassification of Promoter
28th Apr 20233:20 pmRNSResults of Postal Ballot
28th Apr 202311:18 amRNSAppointment of Whole Time Director
27th Apr 202312:44 pmRNSBoard Meeting Outcome - Dividend and Fund Raising
24th Apr 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
29th Mar 20232:49 pmRNSPostal Ballot Notice
27th Mar 20233:47 pmRNSDisclosure under Reg. 30 of SEBI (LODR) Reg. 2015
14th Mar 20231:12 pmRNSRating Action by CRISIL RATINGS LIMITED
13th Mar 20231:56 pmRNSCredit Rating
23rd Feb 20233:17 pmRNSUpdate on acquisition of business undertakings
10th Feb 20231:27 pmRNSCessation of Independent Director
6th Feb 20237:00 amRNSClarification - Bank’s exposure to Adani Group
24th Jan 20237:00 amRNSRevised Press Release and Investor Presentation
11th Jan 20237:00 amRNSBoard Meeting Intimation
13th Dec 202211:44 amRNSAllotment of NCD
7th Dec 20222:49 pmRNSRating Action by ICRA Ratings Limited
7th Dec 20221:55 pmRNSDisclosure under Regulation 30 of SEBI (LODR) Reg
21st Oct 20222:57 pmRNSRATING ACTION BY FITCH RATINGS
21st Oct 202211:40 amRNSRe-appointment of Chief Risk Officer
20th Oct 20222:24 pmRNSAppointment of Additional Independent Director
20th Oct 202212:49 pmRNSOutcome of Board Meeting - October 20, 2022
4th Aug 20223:46 pmRNSUpdate on Sale of Axis Bank UK Limited
2nd Aug 202212:08 pmRNSRegulation 30 - Disclosure of SEBI(LODR) Reg, 2015
29th Jul 20221:53 pmRNSOutcome of Annual General Meeting - July 29, 2022
26th Jul 20222:35 pmRNSApproval of Competition Commission of India

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.